SCHEMBL14519923

SCHEMBL14519923

COc1ccc(Cl)cc1S(=O)(=O)C(C)C

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.55
▸ POLB P06746 2/20 0.55
▸ KDM4E B2RXH2 1/20 0.55
▸ HPGD P15428 1/20 0.55
▸ RAB9A P51151 1/20 0.55
▸ L3MBTL1 Q9Y468 1/20 0.54
▸ TRPV4 Q9HBA0 1/20 0.53
▸ TSHR P16473 2/20 0.52
▸ NPC1 O15118 1/20 0.52
▸ SMN1; SMN2 Q16637 2/20 0.52
▸ WDR5 P61964 1/20 0.51
▸ MAPK1 P28482 1/20 0.49
▸ HTT P42858 2/20 0.47
▸ ALPL P05186 2/20 0.47
▸ LMNA P02545 1/20 0.47
▸ NPSR1 Q6W5P4 1/20 0.47
▸ KMT2A Q03164 2/20 0.46
▸ TP53 P04637 2/20 0.46
▸ GAA P10253 1/20 0.46
▸ MEN1 O00255 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14519874 0.81 L3MBTL1 (0.60) ALDH1A1L3MBTL1SMN1; SMN2MAPK1LMNA
SCHEMBL14520037 0.81 KMT2A (0.57) ALDH1A1POLBL3MBTL1TSHRSMN1; SMN2
SCHEMBL750886 0.80 TRPV4 (0.73) ALDH1A1POLBKDM4EHPGDRAB9A
SCHEMBL4572998 0.80 SMN1; SMN2 (0.65) ALDH1A1POLBKDM4EHPGDRAB9A
SCHEMBL38243330 0.80 TRPV4 (0.73) ALDH1A1POLBKDM4EHPGDRAB9A
SCHEMBL14520042 0.79 MAOB (0.44) ALDH1A1POLBL3MBTL1TSHRSMN1; SMN2
SCHEMBL14519921 0.79 SMN1; SMN2 (0.56) ALDH1A1KDM4ETSHRSMN1; SMN2WDR5
SCHEMBL13290781 0.79 ALDH1A1 (0.58) ALDH1A1POLBKDM4EHPGDRAB9A
SCHEMBL5749988 0.79 PKM (0.58) ALDH1A1POLBKDM4EHPGDRAB9A
SCHEMBL6038929 0.79 ALDH1A1 (0.58) ALDH1A1POLBKDM4EHPGDRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070078146-A1 Antiinflamamtory agents; antiarthritic agents; inflammatory bowel disorders; multiple sclerosis; asthma PHARMACIA CORPORATION 2007-04-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070078146-A1 Antiinflamamtory agents; antiarthritic agents; inflammatory bowel disorders; multiple sclerosis; asthma MAPK1, MAPK3, MAPK4 ALDH1A1 1079/4885POLB 1939/4885KDM4E 2562/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback